Q Therapeutics
Q Therapeutics, Inc., a Salt Lake City-based company, develops cell-based treatments for neurological disorders.
Founded
2005Q Therapeutics, Inc., a Salt Lake City-based company, develops cell-based treatments for neurological disorders.
Q Therapeutics, Inc., founded in Salt Lake City, focuses on developing innovative cell-based therapies for neurological disorders. Their core mission is to create treatments for debilitating and currently incurable diseases of the brain and spinal cord, such as amyotrophic lateral sclerosis, cerebral palsy, stroke, traumatic brain injury, and Alzheimer's disease. Utilizing a unique approach centered on glial cells, Q Therapeutics aims to support, repair, and maintain normal neuron function and health through their proprietary Q-Cells® technology.
Notable affiliated individuals include experienced leaders in biotechnology and neuroscience. The company has garnered attention from investors interested in pioneering medical treatments. Key achievements include advancing their Q-Cells® technology through various stages of development and clinical trials. Overall, Q Therapeutics has made a significant impact on the field of neurotherapeutics by offering potential new treatments for severe CNS disorders, contributing to the broader goal of improving patient outcomes and quality of life.
Companies similar to Q Therapeutics include Neurona Therapeutics, QurAlis, Quentis Therapeutics and Cerebral Therapeutics.
Q Therapeutics was founded in 2005.
Q Therapeutics' headquarters is located in Salt Lake City, UT, US.
Q Therapeutics' most recent funding round was for $5.2M (USD) in January 2017.
As of Jan 19, 2017, Q Therapeutics has disclosed funding of $24.2M (USD). Undisclosed round amounts are excluded.
Q Therapeutics has 5 employees as of Feb 5, 2024.
